BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/12/2026 7:43:29 AM | Browse: 7 | Download: 0
Publication Name World Journal of Psychiatry
Manuscript ID 117187
Country China
Category Psychology, Clinical
Manuscript Type Retrospective Cohort Study
Article Title Alcohol dehydrogenase 4 expression in hepatocellular carcinoma and its association with tumor invasion, survival, and psychological status
Manuscript Source Unsolicited Manuscript
All Author List Tian Xia, Cheng-Li Liu, Jing-Chen Zhang, Pu Meng, Ying-Bo Ma, Qi-Ke Huang, Hao-Ming Li, Xu-Ying Zhao, Cheng Wang, Gang Zhao and Ling-Hong Kong
Funding Agency and Grant Number
Funding Agency Grant Number
Capital Health Development Research Special Project of 2024 No. SF-2024-2-5121
Corresponding Author Cheng-Li Liu, MD, Department of Hepatobiliary Surgery, Air Force Medical Center, Graduate School of Hebei North University, Hebei North University, No. 11 Diamond South Road, Qiaodong District, Zhangjiakou 075031, Hebei Province, China. liuchengli_beijing@163.com
Key Words Hepatocellular carcinoma; Alcohol dehydrogenase 4; Tumor invasiveness; Prognosis; Anxiety; Depression
Core Tip Low alcohol dehydrogenase 4 (ADH4) expression in hepatocellular carcinoma correlates with larger tumors, poor differentiation, high microvascular invasion, reduced 1-year and 3-year survival, and elevated anxiety-depression scores. Multivariate analysis identifies low ADH4 as an independent poor prognostic factor. These findings suggest ADH4 is a valuable biomarker for assessing tumor aggressiveness, predicting outcomes, and identifying patients requiring intensive therapy and psychosocial support, thus enabling personalized oncological and mental-health interventions to improve overall prognosis and quality of life.
Citation Xia T, Liu CL, Zhang JC, Meng P, Ma YB, Huang QK, Li HM, Zhao XY, Wang C, Zhao G, Kong LH. Alcohol dehydrogenase 4 expression in hepatocellular carcinoma and its association with tumor invasion, survival, and psychological status. World J Psychiatry 2026; In press
Received
2025-12-09 09:07
Peer-Review Started
2025-12-09 09:07
First Decision by Editorial Office Director
2025-12-30 05:39
Return for Revision
2025-12-30 05:39
Revised
2026-01-09 09:50
Publication Fee Transferred
2026-01-19 04:23
Second Decision by Editor
2026-02-12 02:50
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-12 07:43
Articles in Press
2026-02-12 07:43
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3206 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com